Medication monitors have seized tests of Johnson and Johnson’s infant powder from a plant in Himachal Pradesh.
J&J India did not have any quick remark on the reports of test seizures by Indian experts.
J&J India did not have any prompt remark on the reports of test seizures by Indian experts.
Indian medication investigators have seized tests of Johnson and Johnson’s infant powder from a plant in Himachal Pradesh, an industry source said on Wednesday, following a Reuters report the organization knew for quite a long time that disease-causing asbestos snuck in the item.
The source, who declined to be named, said the examples were taken from the Baddi plant in Himachal Pradesh on Tuesday night.
J&J India did not have any quick remark on the reports of test seizures by Indian experts. On Tuesday the organization said in an explanation that the Reuters article, which was distributed on Friday, “is uneven, false and provocative”.
“Johnson and Johnson’s infant powder is sheltered and asbestos free,” it included. “Investigations of in excess of 100,000 people demonstrate that powder does not cause malignant growth or asbestos-related malady. A great many autonomous tests by controllers and the world’s driving labs demonstrate our infant powder has never contained asbestos,” the organization said.
Surendranath Sai, a medication officer in Telangana, said he was teaching drug controllers to seize tests there.
“Based on the news reports we are alarmed to get tests. We will test them in a medication control lab here,” said Sai. “We will make a move as needs are Surely we are concerned in light of the fact that a large number of children might be influenced.”